InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by DOUGLAS RICHARD, Director. Director active across 2 companies, notably NOVAVAX INC. Aggregated, 7 filings have been logged. Total volume traded: €394k. The latest transaction was disclosed on 13 December 2021 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
700 shares
Common Stock
SEC:0001209191-22-038592:0·
€33,9471,500 shares@ €22.63120.0023% mcap100.0% of flow
Common Stock
SEC:0001209191-21-069798·
€33,9471,500 shares@ €22.63120.0023% mcap50.0% of flow
Common Stock
SEC:0001209191-21-069798:0·
€197,23820,000 shares@ €9.8619100.0% of flow
Common Stock
SEC:0001209191-21-066289·
Ideal exit: 19 Aug 2022 (T+270)
€197,23820,000 shares@ €9.86190.18% mcap50.0% of flow
Common Stock
SEC:0001209191-21-066289:0·
Ideal exit: 19 Aug 2022 (T+270)
3,450 shares
Common Stock
SEC:0001209191-21-043700·
3,450 shares
Common Stock
SEC:0001209191-21-043700:0·
7 of 7 declarations
About DOUGLAS RICHARD
Richard Douglas is a Board Member at Novavax Inc and MaxCyte, Inc. In this role, he contributes to the governance of both companies by bringing his expertise in the biopharmaceutical sector. Richard plays a key role in evaluating performance and overseeing growth strategies. His industry experience is a valuable asset to the management teams of Novavax and MaxCyte.
